<?xml version="1.0" encoding="UTF-8"?>
<ref id="B1-antibodies-09-00020">
 <label>1.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Krammer</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Fouchier</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Eichelberger</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Webby</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Shaw-Saliba</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wan</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>P.C.</given-names>
   </name>
   <name>
    <surname>Compans</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Skountzou</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Monto</surname>
    <given-names>A.S.</given-names>
   </name>
  </person-group>
  <article-title>NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?</article-title>
  <source>MBio</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>e02332-17</fpage>
  <pub-id pub-id-type="doi">10.1128/mBio.02332-17</pub-id>
 </element-citation>
</ref>
